=== ALLERGIES ===
No Information


=== RESULTS ===
No Results


=== REASON FOR REFERRAL ===
No Information


=== REASON FOR VISIT ===
Lab review


=== MEDICATIONS ===
Medication
SIG (Take, Route, Frequency, Duration)
Notes
Start Date
End Date
Status
Olmesartan Medoxomil-HCTZ 40-12.5 MG
1 tablet Orally Once a day; Duration: 30 days
Active


=== IMMUNIZATIONS ===
No Information


=== SOCIAL HISTORY ===
No Information


=== PROBLEMS ===
Problem Type
SNOMED Code
ICD Code
Onset Dates
Problem Status
W/U Status
Risk
Notes
Problem
Vitamin D deficiency (34713006)
Vitamin D deficiency, unspecified (E55.9)
Active
confirmed
Problem
Disorder of lipoprotein AND/OR lipid metabolism (48286001)
Other lipoprotein metabolism disorders (E78.89)
Active
confirmed
Problem
Hyperlipidemia (55822004)
Hyperlipidemia, unspecified (E78.5)
Active
confirmed
Problem
Essential hypertension (59621000)
Hypertension, unspecified type (I10)
Active
confirmed
Problem
Skin sensation disturbance (80910005)
Tingling of both feet (R20.2)
Active
confirmed


=== VITAL SIGNS ===
No Information


=== PROCEDURES ===
No Information


=== ENCOUNTERS ===
Encounter
Location
Date
Provider
Diagnosis
Epic Heart And Vascular Care
4 HDSN VLY PROF PLZ STE B NEWBURGH, NY 12550-3157
07/19/2025
Shellene Napier-Martin
Annual physical exam Z00.00 ; Person consulting for explanation of examination or test findings Z71.2 ; Hypertension, unspecified type I10 ; Hyperlipidemia, unspecified E78.5 ; SVT (supraventricular tachycardia) I47.10 ; Shortness of breath on exertion R06.02 ; Dizziness R42 ; Lightheadedness R42 ; Leg numbness R20.0 ; Tingling of both feet R20.2 and Abnormal ankle brachial index (ABI) R68.89


=== MEDICAL EQUIPMENT ===
No Information


=== ASSESSMENTS ===
Encounter Date
Diagnosis (ICD Code)
Treatment Notes
Section Notes
encounter date : 07/19/2025
Annual physical exam (ICD-10 - Z00.00)
encounter date : 07/19/2025
Person consulting for explanation of examination or test findings (ICD-10 - Z71.2)
encounter date : 07/19/2025
Hypertension, unspecified type (ICD-10 - I10)
encounter date : 07/19/2025
Hyperlipidemia, unspecified (ICD-10 - E78.5)
encounter date : 07/19/2025
SVT (supraventricular tachycardia) (ICD-10 - I47.10)
encounter date : 07/19/2025
Shortness of breath on exertion (ICD-10 - R06.02)
encounter date : 07/19/2025
Dizziness (ICD-10 - R42)
encounter date : 07/19/2025
Lightheadedness (ICD-10 - R42)
encounter date : 07/19/2025
Leg numbness (ICD-10 - R20.0)
encounter date : 07/19/2025
Tingling of both feet (ICD-10 - R20.2)
encounter date : 07/19/2025
Abnormal ankle brachial index (ABI) (ICD-10 - R68.89)
encounter date : 07/19/2025
Other
Labs
were reviewed and discussed today that showed
an LDL of 129 and an A1C of 5.0. Thyroid function, CMP, hepatic
panel, lipoprotein a, CBC, vitamin D, and apolipoprotein B were
reviewed and found to be within normal limits. Lyme panel was
negative. Due to the mild elevation in LDL, she was advised to adopt
a diet low in saturated fats and high in fiber, as well as to
increase aerobic exercise. A repeat lipid panel is recommended in 3-6
months to assess response to lifestyle modifications. Follow-up is
scheduled for 07/21. She is in agreement with the plan of care.
Patient was informed of the telemedicine visit by our office staff. Telemedicine was described in detail to the patient as the use of synchronous video and audio communication to provide clinical care from a distance. A telemedicine visit can provide the same medical standard of care for specific conditions. The patient was informed that the practice staff located at the provider's office would assist in carrying out any recommendations and clinical care.
Patient Location: Home
Lack of strict HIPPA Rules. Patient expressed verbal interest in the telemedicine visit and granted consent to proceed.


=== PLAN OF TREATMENT ===
Treatment Notes
Assessment
Notes
Other
Labs
were reviewed and discussed today that showed
an LDL of 129 and an A1C of 5.0. Thyroid function, CMP, hepatic
panel, lipoprotein a, CBC, vitamin D, and apolipoprotein B were
reviewed and found to be within normal limits. Lyme panel was
negative. Due to the mild elevation in LDL, she was advised to adopt
a diet low in saturated fats and high in fiber, as well as to
increase aerobic exercise. A repeat lipid panel is recommended in 3-6
months to assess response to lifestyle modifications. Follow-up is
scheduled for 07/21. She is in agreement with the plan of care.
Patient was informed of the telemedicine visit by our office staff. Telemedicine was described in detail to the patient as the use of synchronous video and audio communication to provide clinical care from a distance. A telemedicine visit can provide the same medical standard of care for specific conditions. The patient was informed that the practice staff located at the provider's office would assist in carrying out any recommendations and clinical care.
Patient Location: Home
Lack of strict HIPPA Rules. Patient expressed verbal interest in the telemedicine visit and granted consent to proceed.
Next Appt
Details
Follow Up: 07/21, Reason:
Provider Name:RISHI BAJAJ, 09/15/2025 10:00:00 AM, 4 HDSN VLY PROF PLZ, Suite B, NEWBURGH, NY, 12550-3157, 781-530-0070


=== GOALS SECTION ===
No Information


=== HEALTH CONCERNS ===
No Information


=== INSURANCE PROVIDERS ===
Payer Name
Payer Address
Payer Phone
Subscriber Number
Group Number
Insured Name
Patient Relationship to Insured
Coverage Start Date
Coverage End Date
MVP Health Plan of NY
PO BOX 2207 SCHENECTADY, NY 123012207
800-684-9286
82126914200
Amanna, Courtney
Self - patient is the insured
Medicaid of New York
PO BOX 4601 RENSSELAER, NY 121444602
DG94536D
Amanna, Courtney
Self - patient is the insured


